Related Experiment Video
Updated: Jun 6, 2026
12:04
Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
Published on: August 14, 2012
Pregnane steroidal glycosides and their cytostatic activities
Víctor P García1, Jaime Bermejo, Sara Rubio
1Departamento de Química de Productos Naturales y Biotecnología, Instituto de Productos Naturales y Agrobiología de Canarias, La Laguna, Tenerife, Canary Islands. vpergarw@gobiernodecanarias.org
Glycobiology
|December 15, 2010
Summary
New steroidal glycosides from Ceropegia fusca show promising anticancer activity. Compounds 1 and 2 exhibited significant cytostatic effects against human cancer cell lines, with acetylation enhancing potency against leukemia cells.
Area of Science:
- Natural Product Chemistry
- Pharmacology
- Medicinal Chemistry
Background:
- Ceropegia fusca, an endemic Canary Island plant with traditional medicinal uses, belongs to the Asclepiadaceae family and exhibits crassulacean acid metabolism.
- The dichloromethane extract of Ceropegia fusca has demonstrated significant cytostatic activity against various human cancer cell lines.
Purpose of the Study:
- To isolate and characterize new steroidal glycosides from the aerial parts of Ceropegia fusca.
- To evaluate the in vitro cytotoxic activity of the isolated compounds against human cancer cell lines.
Main Methods:
- Isolation and structural elucidation of four new steroidal glycosides (compounds 1-4) from the aerial parts of Ceropegia fusca.
- Cytotoxicity assays were performed against HL-60 (leukemic), A-431 (epidermoid carcinoma), and SK-MEL-1 (melanoma) human cancer cell lines.
- Chemical modification (acetylation) of an active compound was performed to assess its impact on cytotoxicity.
Main Results:
- Four new steroidal glycosides (1-4) were successfully isolated and characterized.
- Compounds 1 and 2 displayed significant and comparable cytostatic activity against the tested cancer cell lines.
- Acetylation of compound 1 (yielding diacetate 5) resulted in a five-fold increase in cytotoxicity against HL-60 cells, while compounds 3 and 4 showed no significant activity.
- Steroid derivatives with a charged O-amino-benzoyl group demonstrated improved cytotoxicity compared to those with a tigloyl group.
Conclusions:
- Ceropegia fusca is a source of novel steroidal glycosides with potent anticancer properties.
- Compounds 1 and 2 represent promising leads for further development as anticancer agents.
- Structural modifications, such as acetylation and the incorporation of specific functional groups, can significantly enhance the cytotoxic efficacy of these compounds.
Related Concept Videos
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:06Oral Hypoglycemic Agents: Glinides
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...